|

Beta-Adrenergic Antagonist Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Beta Blocker, Beta-Adrenergic Blocking Agent, Beta-Blockers

Top Sponsors

  • Roswell Park Cancer Institute1

Indications

  • Plasma Cell Myeloma1
  • Refractory Plasma Cell Myeloma1
  • Recurrent Plasma Cell Myeloma1
  • Smoldering Plasma Cell Myeloma1
  • Cancer1

Buffalo, New York1 trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.